BioStōm adheres to oral tissue and keeps the wounded area moist while protecting it from irritation and contamination.
Forward Science said it created the gel in response to feedback from dental professionals who said they wanted an oral wound dressing.
The Houston company said it also wanted to create a solution without contributing to the opioid crisis. Up to 10 percent of medical opioids distributed in the U.S. each year are now prescribed by dentists, according to Katie Suda, PharmD, a professor of medicine at the University of Pittsburgh.
“The opioid epidemic has forced the dental industry to reevaluate our approach to pain management to ensure we’re providing holistic care to our patients and preventing adverse outcomes from our prescribing habits,” said Ellen Myers, director of training and education at Forward Science.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
